Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aptose Bioscns (NQ: APTO )

0.1842 -0.0058 (-3.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Aptose Bioscns

< Previous 1 2 3 Next >
Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Gains Over 1%; Ross Stores Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Dow Jumps 300 Points; Gap Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: Aptose Biosciences Q4 Earnings
Via Benzinga
Aptose Biosciences's Earnings: A Preview
Via Benzinga
Aptose Biosciences: Q3 Earnings Insights
Via Benzinga
Expert Ratings for Aptose Biosciences
Via Benzinga
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Hello Group, Zscaler And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Analyst Expectations for Aptose Biosciences's Future
Via Benzinga
Canaccord Genuity Maintains Buy Rating for Aptose Biosciences: Here's What You Need To Know
Via Benzinga
Preview: Aptose Biosciences's Earnings
Via Benzinga
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q4 2023
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
Levi Strauss Layoffs 2024: What to Know About the Latest LEVI Job Cuts
Levi Strauss layoffs are coming for as much as 15% of its corporate workforce as it prepares for a rough economy in 2024! 
Via InvestorPlace
Topics Economy Workforce
Exposures Economy Layoff
Why Is SU Group (SUGP) Stock Moving Today?
SU Group stock volatile on Friday following the company's IPO earlier this week with shares currently trading below its debut price. 
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
Why Is Aptose Biosciences (APTO) Stock Down Today?
Aptose Biosciences stock is sliding lower on Friday as investors react to a public offering and private placement for APTO shares. 
Via InvestorPlace
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Shares of Tellurian Inc. (NASDAQ: TELL) shares rose sharply in pre-market trading following a report suggesting the company hired Lazard to explore a possible sale. Tellurian shares jumped 16.3% to... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning! 
Via InvestorPlace
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash. 
Via Benzinga
RBC Capital Maintains Outperform Rating for Aptose Biosciences: Here's What You Need To Know
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And... 
Via Benzinga
3 Stocks With 1,000% Upside Potential
If you're an investor comfortable with speculative bets, analysts are price targeting these stocks with 1000% upside. 
Via InvestorPlace
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday! 
Via InvestorPlace
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.